US2005129716A1PendingUtilityA1
Therapeutic use of botulinum toxins types A and B
Priority: Jun 10, 1993Filed: Jan 5, 2004Published: Jun 16, 2005
Est. expiryJun 10, 2013(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/16A61P 25/00A61P 29/00A61P 27/02A61P 25/02A61K 38/4893A61P 21/02A61P 21/00Y02A50/30
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating a patient suffering from a disease, disorder or condition includes the administration to the patient of a therapeutically effective amount of botulinum toxin of a selected serotype until the patient experiences loss of clinical response to the administered botulinum toxin and thereafter administering to the patient a therapeutically effective amount of another botulinum toxin of a different serotype.
Claims
exact text as granted — not AI-modified1 . A method of treating a patient suffering from a dystonia, said method comprising administering to the patient a botulinum toxin type A until the patient experiences loss of clinical response to the administered botulinum toxin and thereafter administering to the patient a botulinum toxin type B.
2 - 3 . (canceled)
4 . A method of treating a patient suffering from a dystonia said method comprising administration to the patient a botulinum toxin type A until the patient develops neutralizing antibodies and thereafter administering to the patient a botulinum toxin type B.
5 - 10 . (canceled)Join the waitlist — get patent alerts
Track US2005129716A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.